SakuraBead medical device: resorbable embolic microspheres for the treatment of chronic inflammatory pain.
| Date | Round | Amount |
|---|---|---|
| Feb 2026 | Grant Galway-based CrannMed receives a 12.5 million euro EIC Accelerator grant (2.5 million upfront plus 10 for commercialization) for its pain therapy. | $14.5M |
| Oct 2021 | Grant CrannMed was selected for EIC Accelerator grant-and-equity funding to bring new therapies for knee osteoarthritis to patients, as one of five Irish companies sharing more than €20.5m. | — |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.